PTGX Oct 2024 40.000 call
- Investor's Business Daily
Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
Protagonist Therapeutics is poised to join the S&P SmallCap 600 next Wednesday, replacing copper and aluminum wire manufacturer Encore Wire.
- PR Newswire
Protagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
- Insider Monkey
Is Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
